MEDIFAST INC 8-K

What Happened

• On February 17, 2026, Medifast, Inc. announced its financial results for the fourth quarter and full fiscal year ended December 31, 2025 via a press release. The press release is furnished as Exhibit 99.1 to the company's Form 8-K filed that day. The Form 8-K was signed by CFO James P. Maloney.

Key Details

• Filing date: February 17, 2026.
• Period covered: Fourth quarter and fiscal year ended December 31, 2025.
• The earnings announcement was provided as Exhibit 99.1 (press release) to the Form 8-K.
• The disclosure is furnished (not “filed”) and therefore not subject to Section 18 liability under the Exchange Act.

Why It Matters

• This 8-K contains Medifast’s official earnings announcement for Q4 and FY2025, which is a primary source for investors to assess recent revenue, profitability and operational trends.
• Investors should review the attached press release for the specific revenue, earnings and any management commentary or guidance, and follow up with the company’s 10-K or subsequent filings for full financial detail and context.